Lisinopril Dosing Guidelines and Safety Considerations

Hypertension Dosing

• The 2017 ACC/AHA hypertension guideline recommends initiating lisinopril at 10 mg once daily and titrating up to a maximum of 40 mg once daily for adult patients with primary hypertension, noting that higher doses do not provide additional blood‑pressure benefit. 1

Heart Failure Dosing

• The 2016 ESC heart‑failure guideline advises a target lisinopril dose of 20–35 mg once daily for adults with heart failure with reduced ejection fraction, with dose titration upward as tolerated. 2

Safety Thresholds

• Clinical safety guidance states that a systolic blood pressure below 80 mm Hg constitutes a contraindication to any further lisinopril dose escalation in adult patients. 3

Contraindications in Pregnancy

• All major guideline sources advise that lisinopril should be avoided throughout pregnancy (first, second, and third trimesters) because of teratogenic risk. 1

Drug‑Interaction Precautions

• Guideline recommendations prohibit the concomitant use of lisinopril with angiotensin‑receptor blockers (ARBs) or direct renin inhibitors in adult patients, due to the risk of additive adverse effects such as hyperkalaemia and renal impairment. 1

Laboratory Monitoring After Dose Changes

• After each lisinopril dose increase, clinicians should monitor serum potassium and creatinine levels within 1–2 weeks to detect potential hyperkalaemia or renal function decline. 4